The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2020
Filed:
May. 01, 2018
Applicant:
Biocon Ltd., Bangalore, IN;
Inventors:
Nagaraj Govindappa, Karnataka, IN;
Maria Melina Soares, Karnataka, IN;
Kedernath Sastry, Karnataka, IN;
Assignee:
Other;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01); C07K 16/00 (2006.01); C07K 14/495 (2006.01); C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 16/28 (2006.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); C07K 14/705 (2013.01); C07K 14/71 (2013.01); C07K 16/2818 (2013.01); C12N 15/62 (2013.01); A61K 38/00 (2013.01); C07K 2317/40 (2013.01); C07K 2317/526 (2013.01); C07K 2317/90 (2013.01); C07K 2319/00 (2013.01);
Abstract
The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGFβRII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.